Yvonne E van Riet
Overview
Explore the profile of Yvonne E van Riet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walstra C, Schipper R, Voogd A, van der Sangen M, van Duin R, van Riet Y, et al.
Eur J Surg Oncol
. 2025 Jan;
51(5):109564.
PMID: 39826447
Background: In line with the trend towards minimally invasive, patient-tailored treatment, a selected group of patients with an in-breast tumour recurrence (IBTR) is treated by repeat breast-conserving treatment (BCT). To...
2.
de Bruijn A, Schipper R, Voogd A, Pullens M, Bloemen J, de Munck L, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766087
: Data are lacking on the optimal neoadjuvant systemic treatment (NST) for women with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-positive (HER2+) breast cancer if they are unfit...
3.
Schipper R, de Bruijn A, van der Sangen M, Bloemen J, van den Hoven I, Schepers E, et al.
Eur J Surg Oncol
. 2024 Jun;
50(9):108472.
PMID: 38870876
Background: The aim of the present study was to report the 5-year axillary recurrence-free interval (aRFI) in clinically node-positive breast cancer patients treated according to a de-escalating axillary treatment protocol...
4.
de Jonge C, Schipper R, Walstra C, van Riet Y, Verrijssen A, Voogd A, et al.
Int J Cancer
. 2024 May;
155(7):1237-1247.
PMID: 38752603
Recent studies have reported a higher than expected risk of ipsilateral breast tumor recurrence (IBTR) after breast conserving surgery (BCS) and a single dose of electron beam intra-operative radiotherapy (IORT)....
5.
Schermers B, van Riet Y, Schipper R, Peeters M, Voogd A, Nieuwenhuijzen G, et al.
Br J Surg
. 2021 Oct;
109(1):53-60.
PMID: 34642736
Background: There is a transition from wire-guided localization (WGL) of non-palpable breast cancer to other localization techniques. Multiple prospective studies have sought to establish superior clinical outcomes for radioactive-seed localization...
6.
Schipper R, de Bruijn A, Voogd A, Bloemen J, van Riet Y, Vriens B, et al.
Eur J Surg Oncol
. 2021 May;
47(8):1928-1933.
PMID: 34030918
Background: Data on effectiveness and optimal use of neoadjuvant endocrine therapy (NET) in clinically biopsy-proven node-positive breast cancer is lacking. This study examined the incidence of axillary pathological complete response...
7.
Walstra C, Schipper R, van Riet Y, van der Toorn P, Smidt M, Sangen M, et al.
Breast Cancer Res Treat
. 2021 Mar;
187(2):499-514.
PMID: 33713244
Background: In line with the paradigm to minimize surgical morbidity in patients with primary breast cancer, there is increasing evidence for the safety of a repeat breast-conserving treatment (BCT) of...
8.
van Riet Y, Schipper R, van Merrienboer F, Orsini R, Bloemen J, Jansen F, et al.
Clin Imaging
. 2020 Oct;
69:311-317.
PMID: 33045475
Aim: To evaluate the diagnostic performance for margin assessment of specimen radiography (SR) in breast conserving surgery (BCS) using radioactive I-seed localization (RSL). Methods: The clinical, radiographic and histopathological data...
9.
Walstra C, Schipper R, Poodt I, van Riet Y, Voogd A, van der Sangen M, et al.
Eur J Surg Oncol
. 2019 Feb;
45(8):1317-1327.
PMID: 30795956
The standard of care for patients with an ipsilateral breast tumour recurrence (IBTR) after breast-conserving therapy (BCT) is a salvage mastectomy. However, there is growing interest in the feasibility of...